Yendou is a private company based in Germany that accelerates drug development processes by enhancing operational productivity, streamlining clinical trials, and reducing costs for life sciences companies to improve global health outcomes. It is a study startup management system for oncology research, providing solutions for research sites and sponsors to access new clinical trials, manage teams and facilities, and facilitate communication and information exchange.

Yendou

Hi 👋, we are Yendou, and we are on a mission to harness the transformative power of intelligent automation to unleash the boundless potential of clinical research teams and accelerate medical breakthroughs. Today, we are introducing the life sciences industry to the most advanced and user-friendly Clinical Operation Automation Platform.

We invite the brightest minds to join us in our mission to pioneer the next evolution in clinical research with AI-powered automation.

Together, we can empower clinical research teams to create clinical operation automations that streamline research and make the world a healthier place for everyone.

Headquartered in Germany, Yendou is enabling global companies (Pharma/BioTech; CROs & SMOs) to streamline large-scale clinical trials with automation.

Why let Friday impact your performance?

#Yendou #YendouForClinOps 

With over 100 clinical trials up and running, we just got the biggest Oncology Research Network in Brazil onboard! Welcome #Brazil!

Feasibility team feedback "We love it!"

We love it too! Can't wait to make the clinical trial participation journey fun for everyone.

#clinicaltrials #oncology  #ClinicalTrialsWithoutBorders 

We got our first oncology research center joining us from the Republic of Korea 🇰🇷 
-
Connecting the world of clinical research is fun so far.

#clinicalresearch 

📢 Exciting News! 🌟
In only 7 weeks, Yendou has expanded its reach, becoming home to renowned oncology research sites with over 5 years of breast cancer research experience across 21 countries! 🌍🌎🌏

🇧🇷 Brazil
🇧🇬 Bulgaria
🇨🇦 Canada
🇨🇱 Chile
🇨🇴 Colombia
🇨🇿 Czechia
🇩🇪 Germany
🇪🇸 Spain
🇮🇳 India
🇮🇹 Italy
🇲🇽 Mexico
🇵🇪 Peru
🇵🇭 Philippines
🇵🇱 Poland
🇵🇹 Portugal
🇷🇺 Russia
🇸🇰 Slovakia
🇨🇭 Switzerland
🇹🇷 Türkiye
🇺🇸 United States

That's right! We are now operating in an impressive total of 21 countries! 🌟🎉

At Yendou, our mission is to connect the world of clinical research and streamline oncology clinical trials portfolio delivery to sites at scale and speed. Our North Star is achieving a 90-day timeline from feasibility to RtE by 2025 for oncology trials. 

To make this vision a reality, we are focused on:

✅ Getting everyone on board

✅ Breaking silos between all parties involved (Sponsor/CRO/Sites)

✅ Eliminating redundancies and work about work

✅ Building trust enabling technology, as trust is the key feature of seamless collaboration!

Every day, we are working tirelessly - with tons of fun - to turn this mission into reality.

Today, I want to celebrate all the oncology research sites and amazing Key Opinion Leaders (KOLs) who have joined us on this journey. Together, we are making a significant impact in advancing oncology research worldwide.

A huge shoutout to the Yendou team who has been working relentlessly to make it happen. You rock! 🙌

Stay tuned for more exciting updates as we continue to push the boundaries of oncology research and build the ClinOps infrastructure of the future. Together, we create a difference. 💪

#Yendou #OncologyResearch #ClinicalTrials #GlobalExpansion #Collaboration #MakingADifference #BreastCancerResearch

Metric
Company Name	Yendou
Symbol
MSH ID	IO:YENDOU
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Life Sciences and Healthcare Technology
Country	DE
Stage
Employee Count	3
Website	yendou.io
LinkedIn	itsyendou
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

IO:YENDOU

Yendou

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue